Rhodiola rosea ist eine Wurzel aus kalten Klimaten, die bei Erschöpfung und Stress eingenommen wird; für diese beiden Anwendungsgebiete sind die modernen Evidenzen am stärksten. Innerhalb weniger Wochen senkt ein standardisiertes Wurzelextrakt die Werte für stressbedingte Müdigkeit und Burnout, schärft die Konzentration, lindert leichte Angstzustände und gedrückte Stimmung und dämpft den morgendlichen Anstieg des Stresshormons Cortisol. In einer kleinen Direktvergleichsstudie führte es zu einer geringeren Verbesserung bei leichter Depression als das Antidepressivum Sertralin, wobei die Studie jedoch zu klein war, um einen zuverlässigen Unterschied festzustellen, und deutlich weniger Nebenwirkungen verursachte.
Es schärft das Denken nicht bei Menschen, die bereits ausgeruht sind. Der Haken liegt in der Evidenz selbst: Die Studien sind klein, kurz, werden von wenigen Forschungsteams durchgeführt, die oft mit den Herstellern des Extrakts verbunden sind, weisen eine gemischte Qualität auf und keine hat einen Zeitraum über zwölf Wochen hinaus untersucht. Nehmen Sie ein standardisiertes Wurzelextrakt in einer Dosis von 200 bis 400 mg am Morgen, führen Sie einen definierten Test über einige Wochen durch und beurteilen Sie es anhand Ihrer eigenen Empfindungen.
Findings & Outcomes
What It Is
Rhodiola rosea is a hardy plant that grows in cold, high places across the Arctic and the mountains of Europe and Asia. The root and rhizome are the parts used. It belongs to the group of herbs called adaptogens, plants said to help the body cope with stress, and people take it mainly to feel less tired and less stressed. That is where the human evidence is strongest, and strongest here still means small, short trials of a few standardized extracts. Modern supplements use a root extract standardized to two marker compounds, rosavins and salidroside, in roughly the ratio the trials used.
Rhodiola has a long empirical record behind its modern use. In Scandinavia and across Siberia it was a folk remedy for fatigue, cold, and hard physical work, and Carl Linnaeus documented its use in eighteenth-century Sweden. From the 1940s onward, Soviet and Scandinavian scientists studied it for decades as an adaptogen. They tested it in athletes, soldiers, students, and cosmonauts as a plant to sustain performance and recovery under strain, work that was treated at times as a state secret. Much of that research appeared in Russian and sits outside the modern controlled-trial literature. That research is a long record of practical use, which the later trials then tested. Panossian and colleagues' 2010 review gathers this traditional and Soviet-era record alongside the modern pharmacology.
How It Works
Rhodiola's extract carries many active compounds at once, chiefly rosavins and salidroside. It works as a whole-plant preparation acting on several systems, and no single molecule accounts for its effects. The best-mapped effect is on the body's response to stress, and the anti-fatigue benefit looks like rhodiola dampening that response under load. That is why its clearest effects show up in people who are already depleted and fade in people who are rested. These mechanisms are plausible and partly measured; none is settled.
Anatomy of the Practice
1A root, standardized to two markers
The studied preparation is a concentrated root and rhizome extract, usually standardized to about 3% rosavins and 1% salidroside, the ratio used in the trials. Products vary in how they are made and what they contain, which is one reason a result shown for one extract does not automatically carry to another.
2On the stress response
In the strongest fatigue trial, rhodiola blunted the surge of the stress hormone cortisol that normally follows waking. That is the mechanism researchers tie most directly to its effect on how tired and stressed people feel.
3Activating, and why timing matters
Rhodiola is activating, which fits its use for fatigue and low energy and its history as a stimulant. That activating quality is why the dose is taken earlier in the day, and why a few people find it too stimulating.
What It Does
Rhodiola's findings fall into a clear order of strength. Fatigue and stress sit at the top: this is the use with the most controlled support and the longest folk and Soviet-era record behind it. The two lines of evidence agree. Mood comes next, backed by a handful of small placebo-controlled trials, among them an 89-person depression trial and a smaller 57-person comparison against sertraline. Raw physical performance and thinking in already-rested people sit lowest, where a single dose does little and daily dosing does nothing. The findings below are graded on that basis.
One caveat shapes how much weight each finding carries. Almost every human trial of rhodiola shares the same limits:
- It is small, from a few dozen to about a hundred people.
- It is short, running from a single dose to twelve weeks, with nothing measured beyond that.
- It tests one of only a few standardized extracts, so a result for one product may not carry to another.
- It comes from a few research groups, several tied to the extract makers, with little independent replication.
Two independent systematic reviews that pooled these trials reached the same verdict: the studies are mixed in quality and at high or unclear risk of bias. A rigorous, well-reported randomized trial is still needed. That does not make the results wrong, and the fatigue and stress trials tend to agree. It means the effects read as early and specific to the extracts and doses studied.
Rhodiola's clearest use is a defined few-week trial for fatigue and stress, judged against how you feel. A diagnosed mood condition is a decision to make with a clinician.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Energy And Fatigue
Weniger geistige Erschöpfung unter Stress in zwei kleinen placebokontrollierten Studien
In zwei kleinen Studien, die während stressreicher Wochen liefen, einer Prüfungsperiode und Nachtschichten im Krankenhaus, fühlten und zeigten sich Menschen, die einen standardisierten Rhodiola-Extrakt einnahmen, weniger geistig erschöpft als Menschen unter Placebo.
Darbinyan 2000 gab 56 jungen gesunden Ärzten einen standardisierten SHR-5-Extrakt oder Placebo in einer doppelblinden Crossover-Studie während zweiwöchiger Nachtdienstblöcke und fand während der ersten zwei Wochen eine statistisch signifikante Verbesserung eines Erschöpfungsindex, der aus Tests zu assoziativem Denken, Kurzzeitgedächtnis, Rechnen, Konzentration und audiovisueller Wahrnehmung gebildet wurde. Spasov 2000 randomisierte ausländische Studenten über eine 20-tägige Prüfungsperiode auf SHR-5 oder Placebo und fand die deutlichsten Zugewinne bei körperlicher Fitness, geistiger Erschöpfung und Neuromotorik-Tests (P<0.01), mit besserem allgemeinem Wohlbefinden (P<0.05), während sich Textkorrektur- und Tapping-Tests nicht unterschieden, und die Autoren hielten die Dosis für wahrscheinlich suboptimal. Beide sind klein, kurz und testen einen Extrakt, das Signal ist also früh, nicht gesichert.
The studies · 2
Darbinyan 2000, Phytomedicine · Phytomedicine
Spasov 2000, Phytomedicine · Phytomedicine
Anxiety And Stress
Weniger Burnout als unter Placebo über 28 Tage bei 60 Erwachsenen mit stressbedingter Erschöpfung
In der stärksten kontrollierten Studie verbesserten sich Erwachsene mit diagnostizierter stressbedingter Erschöpfung über vier Wochen unter Rhodiola stärker als unter Placebo: weniger Burnout, schärfere Konzentration und ein kleinerer morgendlicher Stresshormonanstieg.
Olsson 2009 war eine randomisierte, doppelblinde, placebokontrollierte Parallelgruppenstudie der Phase III mit 60 Männern und Frauen im Alter von 20 bis 55 Jahren, die die schwedischen nationalen Kriterien für ein Erschöpfungssyndrom erfüllten. Beide Gruppen verbesserten sich (ein Placeboeffekt war vorhanden), doch im direkten Vergleich übertraf SHR-5 (576 mg Extrakt/Tag über 28 Tage) Placebo auf der Pines-Burnout-Skala und bei kontinuierlichen Leistungs-Aufmerksamkeitsindizes (Auslassungen, Variabilität der Reaktionszeit), und die Cortisol-Aufwachreaktionen von vor bis nach der Behandlung unterschieden sich in der Behandlungsgruppe signifikant. Dies ist eine einzelne kleine, kurze Studie zu einem einzelnen Extrakt, und die Burnout-Skala ist ein Selbstberichtsmaß.
The study · 1
Olsson 2009, Planta Med · Planta Med
Burnout- und Lebensstress-Symptome besserten sich in drei offenen Studien ohne Placebogruppe
In drei Studien, bei denen alle wussten, dass sie Rhodiola einnahmen, und es keine Placebogruppe gab, berichteten Menschen mit Burnout, Lebensstress oder lang andauernder Erschöpfung, sich in den folgenden Wochen besser zu fühlen.
Kasper 2017 (118 Burnout-Ambulanzpatienten, 400 mg/Tag WS 1375 über 12 Wochen), Edwards 2012 (101 Lebensstress-Patienten, 200 mg zweimal täglich über 4 Wochen) und Lekomtseva 2017 (100 Patienten mit anhaltender oder chronischer Erschöpfung, 200 mg zweimal täglich über 8 Wochen) waren alle offene Einarmstudien: keine Kontrollgruppe, keine Verblindung, und die Autoren beschreiben sie als explorative, hypothesengenerierende Pilotstudien. Die Symptomskalen besserten sich im Zeitverlauf, oft bereits in der ersten Woche. Ohne Placeboarm können diese Designs den Effekt des Extrakts nicht von Erwartung und dem natürlichen Abklingen der Symptome trennen, weshalb sie unter den kontrollierten Studien eingeordnet werden.
The studies · 3
Kasper 2017, Neuropsychiatr Dis Treat · Neuropsychiatr Dis Treat
Edwards 2012, Phytother Res · Phytother Res
Lekomtseva 2017, Complement Med Res · Complement Med Res
Mood & stress
Weniger Angst und gedrückte Stimmung über 14 Tage im Vergleich zu einer unbehandelten Kontrollgruppe
Leicht ängstliche Erwachsene, die zwei Wochen lang Rhodiola einnahmen, berichteten weniger Angst, Stress und gedrückte Stimmung als eine Gruppe, die nichts einnahm.
Cropley 2015 randomisierte 80 leicht ängstliche Teilnehmer über 14 Tage auf einen Rhodiola-Extrakt (2 x 200 mg/Tag) oder eine unbehandelte Kontrollgruppe. Die Rhodiola-Gruppe zeigte signifikante Senkungen bei selbstberichteter Angst, Stress, Ärger, Verwirrung und Depression und eine verbesserte Gesamtstimmung, bei günstigem Verträglichkeitsprofil. Die zentrale Einschränkung ist das Design: Die Kontrollgruppe erhielt keine Behandlung, kein Placebo, und die Studie war nicht verblindet, die Erwartung ist also nicht kontrolliert. Die Autoren argumentieren, dass das allmähliche, symptomspezifische Muster einen reinen Placeboeffekt weniger wahrscheinlich macht, geben aber an, dass sie keinen kausalen Zusammenhang belegen können.
The study · 1
Cropley 2015, Phytother Res · Phytother Res
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Die Depressionswerte sanken um 5.1 unter Rhodiola, 8.2 unter Sertralin, 4.6 unter Placebo, ohne verlässlichen Unterschied
In einer kleinen direkten Vergleichsstudie lag Rhodiola bei Depression zwischen dem Antidepressivum Sertralin und Placebo, doch die Studie war zu klein, um einen dieser Unterschiede verlässlich zu machen.
Mao 2015 war eine randomisierte, placebokontrollierte Machbarkeitsstudie der Phase II: 57 Erwachsene mit leichter bis mittelschwerer Major Depression wurden über 12 Wochen auf standardisierten Rhodiola-Extrakt, Sertralin oder Placebo verteilt. Die Senkungen der Werte auf der Hamilton-Depressionsskala waren bescheiden und unterschieden sich nicht signifikant zwischen den Gruppen (p=0.79); die Punktschätzer waren am größten für Sertralin (-8.2, 95%-KI -12.7 bis -3.6), mittel für Rhodiola (-5.1, 95%-KI -8.8 bis -1.3) und am kleinsten für Placebo (-4.6). Die Studie war explizit nicht ausreichend aussagekräftig, um Wirksamkeit zu beweisen; ihr klarerer Befund betrifft die Verträglichkeit, bei der Rhodiola weit weniger unerwünschte Ereignisse verursachte als Sertralin.
The study · 1
Mao 2015, Phytomedicine · Phytomedicine
Mild-to-moderate depression improved on rhodiola but not placebo in an 89-person, 6-week trial
In an earlier six-week trial, people with mild-to-moderate depression improved on rhodiola across most symptoms while the placebo group did not.
Darbinyan 2007 was a randomized, double-blind, placebo-controlled parallel-group trial in 89 men and women aged 18 to 70 with mild-to-moderate depression (Hamilton scores 21 to 31). Two active groups (340 mg/day and 680 mg/day of SHR-5 for 6 weeks) showed significant improvement in overall depression plus insomnia, emotional instability and somatization, whereas the placebo group did not; self-esteem did not improve, and no serious side effects were reported. It is a single small trial from one research group, and it has not been independently replicated at this size.
The study · 1
Darbinyan 2007, Nord J Psychiatry · Nord J Psychiatry
Cardiorespiratory Fitness
Eine Einzeldosis erhöhte die Ausdauer leicht von 16.8 auf 17.2 Minuten; tägliche Dosierung bewirkte nichts
Als Einzeldosis eine Stunde vor dem Training eingenommen, brachte Rhodiola einen kleinen Zuwachs an Ausdauer, hauptsächlich indem die Anstrengung leichter erschien. Die tägliche Einnahme über vier Wochen brachte nichts Zusätzliches.
De Bock 2004 (n=24, doppelblinde Placebo-Crossover-Studie) fand, dass eine akute Dosis von 200 mg die Zeit bis zur Erschöpfung von 16.8 auf 17.2 Minuten erhöhte und die maximale Sauerstoffaufnahme steigerte, doch eine vierwöchige Phase täglicher Einnahme brachte bei keinem Maß eine Veränderung. Noreen 2013 (n=18, doppelblinde Crossover-Studie) fand, dass eine akute Dosis von 3 mg/kg ein 6-Meilen-Radzeitfahren von 25.8 auf 25.4 Minuten beschleunigte und die empfundene Anstrengung sowie die Aufwärm-Herzfrequenz senkte, ohne Veränderung bei den meisten anderen Variablen. Die Effekte sind klein, stammen aus einzelnen akuten Dosen bei winzigen Stichproben, und der einzige Arm mit chronischer Dosierung war ohne Effekt.
The studies · 2
De Bock 2004, Int J Sport Nutr Exerc Metab · Int J Sport Nutr Exerc Metab
Noreen 2013, J Strength Cond Res · J Strength Cond Res
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Cognition
Kein schärferes Denkvermögen, keine schärfere Reaktionszeit oder Aufmerksamkeit bei bereits ausgeruhten Menschen
Bei Menschen, die nicht erschöpft waren, schärfte Rhodiola Denkvermögen, Reaktionszeit oder Aufmerksamkeit nicht über das hinaus, was eine Kontrollgruppe zeigte.
Die Studien gegen Erschöpfung messen die Leistung unter Stress oder Schlafmangel, wo Rhodiola ein Signal zeigt. Wird die Kognition bei ausgeruhten Menschen gemessen, ist das Bild flach: Cropley 2015 fand trotz der Stimmungsverbesserung keinen Gruppenunterschied bei kognitiven Tests, und die vierwöchige Phase täglicher Dosierung von De Bock 2004 fand keine Veränderung bei auditiver oder visueller Reaktionszeit, Plättchen-Tapping-Geschwindigkeit oder anhaltender Aufmerksamkeit. Der scheinbare Nutzen scheint an das Entgegenwirken von Erschöpfung gebunden zu sein, nicht an eine Anhebung der grundlegenden kognitiven Fähigkeit.
The studies · 2
Cropley 2015, Phytother Res · Phytother Res
De Bock 2004, Int J Sport Nutr Exerc Metab · Int J Sport Nutr Exerc Metab
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Evidence And Methods
All 11 fatigue trials carried a high or unclear risk of bias, with little independent replication
When reviewers gathered the trials and graded them, they found the studies small, short, and shaky in quality, and rarely repeated by a second independent team. The direction is encouraging; the certainty is not there yet.
Ishaque 2012 systematically reviewed 11 trials of rhodiola for physical and mental fatigue and concluded that every included study had either a high risk of bias or reporting flaws that made its true validity unclear, that results were contradictory, and that a rigorous well-reported RCT is still needed. Hung 2011 reviewed 11 placebo-controlled RCTs across physical performance, mental performance and mental-health conditions, rated most as moderate or good quality on the Jadad scale, but found a lack of independent replication of any single finding. This describes the state of the evidence base, not the direction of the effect: the trials tend to point the same way, but their size, independence and risk of bias are the reasons to hold the conclusion loosely.
The studies · 2
Ishaque 2012, BMC Complement Altern Med · BMC Complement Altern Med
Hung 2011, Phytomedicine · Phytomedicine
Getting the Dose and Timing Right
Ways to Do It
The practical protocol is short: a standardized root extract, taken earlier in the day, for a defined stretch of weeks. Read the Cautions section below first, because a few situations make it a poor fit. No brand is named here on purpose; the form, the dose, the timing, and a full trial period are what decide whether it works for you.
The trials used a root and rhizome extract standardized to roughly 3% rosavins and 1% salidroside. Effective daily doses in the studies ranged from about 200 mg up to around 600 mg, with 400 mg a day the most common in the stress and fatigue trials. Standardization varies between products, so the label worth checking states its rosavin and salidroside content and carries an independent testing mark.
Rhodiola is stimulating, and the trials dosed it earlier in the day. Taken late it can be activating enough to disturb sleep in some people. A morning dose, or morning and early afternoon if you split it, keeps the effect where you want it and away from the night.
Any effect builds over days to weeks, and the trials ran from about four to twelve weeks, so that is the window the evidence covers. Take it across that stretch and judge it against how you felt at the start. The trials found the effect, when it came, inside that window, and say nothing about a benefit appearing later. Pair it with the practices that have stronger evidence for the same goals, linked below.
Go Deeper
- Ashwagandha: the other adaptogenic root taken for stress and sleep, with a similar small-trial evidence base and safety signals of its own to read.
- Breath and heart-rate variability: a free, well-evidenced way to act on the same stress response, with no supplement to weigh.
- The CBT-I protocol: the first-line, best-evidenced approach to poor sleep, to try before or alongside anything taken for stress-related sleeplessness.
The Chinese Medicine View
Rhodiola is best known in Tibetan medicine, where the plant, called Hong Jing Tian in Chinese, has a long history of use in the cold high country where it grows. It entered the Chinese materia medica later than the classical staples and is a relatively modern addition. It does not carry the centuries of commentary that an herb like ginseng does. In this tradition it is used as a medicinal in its own right.
In Chinese medicine terms, Hong Jing Tian is understood to tonify Qi, particularly of the Lung and Heart. It is also said to invigorate the Blood and move Blood stasis, and to clear heat from the Lung. Practitioners have used it for Qi deficiency with Blood stasis, for shortness of breath and cough, and for the fatigue and altitude strain of high, cold environments. That framing sits close to the modern use for fatigue and stress: a plant taken when energy and resilience run low. Rhodiola's standing rests on that long record of practical use as much as on the modern trials that point the same way. The Chinese framing offered here connects it to the rest of this library; it is not a claim that the tradition predicted the trial results.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Few side effects over weeks, and fewer than sertraline (30% versus 63.2%)
Hung 2011, reviewing 11 placebo-controlled RCTs, reported only a few mild adverse events across the trials. Mao 2015 found adverse events in 30% of the rhodiola group versus 63.2% on sertraline and 16.7% on placebo (p=0.012), and concluded rhodiola was better tolerated. These are reassuring short-term data measured over weeks to a few months; they say nothing about use over many months or years, and the trials are too small to detect uncommon harms.Hung 2011, PhytomedicineMao 2015, Phytomedicine
No trial ran longer than twelve weeks; long-term, pregnancy and breastfeeding use unstudied
The controlled trials of rhodiola run from a single acute dose to about twelve weeks. Ishaque 2012 and Hung 2011 both conclude that the evidence base is too small and too short to support firm conclusions and that rigorous, longer, independently replicated trials are needed. There is no controlled safety data for use beyond a few months, and pregnancy, breastfeeding and interactions with medication have not been formally studied, which is why the practical guidance keeps use to a defined trial period and treats those situations as reasons for care.Ishaque 2012, BMC Complement Altern MedHung 2011, Phytomedicine
It is stimulating, so keep it out of the evening
Rhodiola is activating for most people. Some find it energizing, and some find it too much: jitteriness, restlessness, irritability, or trouble sleeping if it is taken late in the day or at a higher dose. Taking it in the morning, starting at the lower end of the dose range, and easing up if you feel wired keeps it comfortable for most people.
Take care if you have bipolar disorder
Because rhodiola is activating and has an antidepressant-like effect in some trials, there is a reasonable concern that it could tip someone with bipolar disorder toward agitation or a manic or hypomanic state. If you have bipolar disorder or a history of mania, make this decision with the clinician who manages your care.
Pregnancy and breastfeeding: the data is not there
Rhodiola has not been studied in pregnancy or breastfeeding, so there is no basis for judging its safety in those situations. The cautious course is to avoid it while pregnant, trying to conceive, or breastfeeding until there is evidence to rely on.
It may interact with some medications
Given its effects on mood and stimulation, take care combining rhodiola with antidepressants, stimulants, or other mood medication, where the effects could add up. Raise it with your clinician or pharmacist if you take medication with a narrow margin of safety, such as for blood pressure, blood sugar, or blood thinning. When in doubt, check before combining.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does rhodiola actually help with fatigue?
In small short trials, it points that way. The strongest controlled trial, in 60 adults with a stress-related fatigue syndrome, found less burnout and better concentration on a standardized extract than on placebo over four weeks. Two more trials during real stress, exams and hospital night shifts, found less mental fatigue. The caution is that these trials are small, brief, and mostly from a few groups. When reviewers graded the wider literature they found it contradictory and of high or uncertain quality. It is an early, promising signal for fatigue and stress that larger trials have yet to confirm.
Is rhodiola a reliable adaptogen that beats stress?
The stress and fatigue results are modest and early. The marketing that presents rhodiola as a dependable stress cure claims far more than the results show. The controlled trials show a short-term effect on stress-related fatigue and mood, and several open-label trials in burnout and life stress report people improving. Without a placebo group those cannot separate the extract's effect from expectation, which strongly shapes how someone feels under stress, so they support the case without settling it. The evidence is still small, short, and thin on independent replication. Give rhodiola a defined trial for stress and fatigue, judged on how you feel.
How much should I take, and when?
The trials used a root extract standardized to about 3% rosavins and 1% salidroside, at roughly 200 to 600 mg a day. In the stress and fatigue studies, 400 mg a day was the most common. Take it in the morning, because rhodiola is stimulating and a late dose can disturb sleep. Give it a defined stretch of about four to twelve weeks, the window the evidence covers, and judge it against how you felt at the start.
Can rhodiola help with depression or anxiety?
The evidence is early and should not be oversold. One 89-person trial found people with mild-to-moderate depression improved on rhodiola across most symptoms while the placebo group did not. A small 57-person head-to-head trial placed rhodiola between the antidepressant sertraline and placebo, though that trial was too small for the differences to be reliable. For anxiety, a two-week trial found lower self-reported anxiety and stress, though its comparison group took nothing instead of a placebo. Part of the change reflects the ordinary lift of taking something and expecting to improve, which matters in its own right. Rhodiola is not a treatment for clinical depression; a mood condition is a good reason to bring a clinician into the decision.
Does rhodiola have side effects?
For most people, over the weeks the trials covered, few. A review of eleven controlled trials found only a few mild adverse events. In the depression trial far fewer people reported side effects on rhodiola than on sertraline, 30% against 63.2%. The main thing people notice is that it can be too stimulating, especially late in the day or at higher doses. Longer-term use has not been studied, and it has not been studied in pregnancy or breastfeeding, so those and the interactions above are the situations to take seriously. The Cautions section above has the detail.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 19 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.